George J. Marlo

Array ( [id] => 1389122 [patent_doc_number] => 06548531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-15 [patent_title] => 'Method for cancer therapy' [patent_app_type] => B2 [patent_app_number] => 10/055451 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7499 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548531.pdf [firstpage_image] =>[orig_patent_app_number] => 10055451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253630 [patent_doc_number] => 06670384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Methods of administering epothilone analogs for the treatment of cancer' [patent_app_type] => B2 [patent_app_number] => 10/055653 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8311 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670384.pdf [firstpage_image] =>[orig_patent_app_number] => 10055653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418269 [patent_doc_number] => 06518301 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Estrogen receptor- ligands' [patent_app_type] => B1 [patent_app_number] => 09/959032 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4933 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518301.pdf [firstpage_image] =>[orig_patent_app_number] => 09959032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265747 [patent_doc_number] => 06660879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-09 [patent_title] => '3-aryl-2-hydroxypropionic acid derivative I' [patent_app_type] => B2 [patent_app_number] => 10/039868 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9297 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660879.pdf [firstpage_image] =>[orig_patent_app_number] => 10039868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6274882 [patent_doc_number] => 20020106405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Pharmaceutical composition for piperidinoalkanol compounds' [patent_app_type] => new [patent_app_number] => 10/039798 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14926 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106405.pdf [firstpage_image] =>[orig_patent_app_number] => 10039798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1415610 [patent_doc_number] => 06506400 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Antiinfective free intramammary veterinary composition' [patent_app_type] => B1 [patent_app_number] => 10/028987 [patent_app_country] => US [patent_app_date] => 2001-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2427 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506400.pdf [firstpage_image] =>[orig_patent_app_number] => 10028987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936725 [patent_doc_number] => 20020061911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Enantiomers of 6-amino EM-12 and method of use' [patent_app_type] => new [patent_app_number] => 10/026291 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6914 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061911.pdf [firstpage_image] =>[orig_patent_app_number] => 10026291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313511 [patent_doc_number] => 06610726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Compositions and agents for modulating cellular proliferation and angiogenesis' [patent_app_type] => B2 [patent_app_number] => 10/026672 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 10393 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610726.pdf [firstpage_image] =>[orig_patent_app_number] => 10026672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096636 [patent_doc_number] => 20020052325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Anticonvulsant derivatives useful in maintaining weight loss' [patent_app_type] => new [patent_app_number] => 10/022928 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1884 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052325.pdf [firstpage_image] =>[orig_patent_app_number] => 10022928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546838 [patent_doc_number] => 20020137801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'METHODS AND COMPOSITIONS TO TREAT CONDITIONS ASSOCIATED WITH NEOVASCULARIZATION' [patent_app_type] => new [patent_app_number] => 10/020526 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6256 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137801.pdf [firstpage_image] =>[orig_patent_app_number] => 10020526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414541 [patent_doc_number] => 06525058 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Pharmaceutical composition for oral use' [patent_app_type] => B1 [patent_app_number] => 10/009797 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4841 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525058.pdf [firstpage_image] =>[orig_patent_app_number] => 10009797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097080 [patent_doc_number] => 20020052398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Pharmaceutical composition of 6-amino EM-12' [patent_app_type] => new [patent_app_number] => 10/015252 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6909 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052398.pdf [firstpage_image] =>[orig_patent_app_number] => 10015252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082696 [patent_doc_number] => 20020082290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'PHARMACEUTICAL COMPOSITION OF 3-AMINO THALIDOMIDE' [patent_app_type] => new [patent_app_number] => 10/020391 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6908 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082290.pdf [firstpage_image] =>[orig_patent_app_number] => 10020391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601289 [patent_doc_number] => 06476068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Platinum derivative pharmaceutical formulations' [patent_app_type] => B1 [patent_app_number] => 10/010122 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3448 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476068.pdf [firstpage_image] =>[orig_patent_app_number] => 10010122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645574 [patent_doc_number] => 06472395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Agent for use in transplantation' [patent_app_type] => B1 [patent_app_number] => 09/914300 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 3182 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472395.pdf [firstpage_image] =>[orig_patent_app_number] => 09914300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1400928 [patent_doc_number] => 06537985 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Antibiotic formulation and a method of making this formulation' [patent_app_type] => B1 [patent_app_number] => 09/997978 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2072 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537985.pdf [firstpage_image] =>[orig_patent_app_number] => 09997978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653387 [patent_doc_number] => 20030008887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines' [patent_app_type] => new [patent_app_number] => 10/001868 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18529 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008887.pdf [firstpage_image] =>[orig_patent_app_number] => 10001868 [rel_patent_id] =>[rel_patent_doc_number] =>)